Zhang Y, Fu Q, Sun W, Yue Q, He P, Niu D
J Transl Med. 2025; 23(1):313.
PMID: 40075523
PMC: 11899831.
DOI: 10.1186/s12967-025-06306-8.
Huang G, Zhou M, Lu D, Li J, Tang Q, Xiong C
Front Oncol. 2024; 14:1421902.
PMID: 39169946
PMC: 11335651.
DOI: 10.3389/fonc.2024.1421902.
Nguyen J, Chong T, Elmi H, Ma J, Madi J, Mamgain A
Cancers (Basel). 2023; 15(9).
PMID: 37173998
PMC: 10177336.
DOI: 10.3390/cancers15092533.
Liang Y, Liu W, Zhao M, Shi D, Zhang Y, Luo B
Virus Genes. 2023; 59(2):204-214.
PMID: 36738378
DOI: 10.1007/s11262-023-01970-8.
Menko A, Walker J
Biomolecules. 2022; 12(9).
PMID: 36139020
PMC: 9496593.
DOI: 10.3390/biom12091181.
Laminin 332-functionalized coating to regulate the behavior of keratinocytes and gingival mesenchymal stem cells to enhance implant soft tissue sealing.
Liu L, Wang J, Li Y, Liu B, Zhang W, An W
Regen Biomater. 2022; 9:rbac054.
PMID: 36072266
PMC: 9438747.
DOI: 10.1093/rb/rbac054.
KRAS Mutants Upregulate Integrin β4 to Promote Invasion and Metastasis in Colorectal Cancer.
Choi S, Kim J, Chen C, Wu C, Marco M, Barriga F
Mol Cancer Res. 2022; 20(8):1305-1319.
PMID: 35394541
PMC: 9357101.
DOI: 10.1158/1541-7786.MCR-21-0994.
Revising the Role of Integrin Subunit β4 Expression in Colon Cancer Progression and Survival.
Rademaker E, Bastiaannet E, Oosting J, Dekker-Ensink N, Kuppen P, de Miranda N
J Gastrointest Cancer. 2022; 54(1):147-154.
PMID: 35112314
PMC: 10182939.
DOI: 10.1007/s12029-021-00787-8.
ITGB4 deficiency induces mucus hypersecretion by upregulating MUC5AC in RSV-infected airway epithelial cells.
Du X, Yang Y, Yang M, Yuan L, Wang L, Wu M
Int J Biol Sci. 2022; 18(1):349-359.
PMID: 34975337
PMC: 8692133.
DOI: 10.7150/ijbs.66215.
Integrins regulate stemness in solid tumor: an emerging therapeutic target.
Xiong J, Yan L, Zou C, Wang K, Chen M, Xu B
J Hematol Oncol. 2021; 14(1):177.
PMID: 34715893
PMC: 8555177.
DOI: 10.1186/s13045-021-01192-1.
Targeting cancer stem cells integrin β4.
Dobson H, Ruan S, Chang A, Wicha M, Li Q
Oncotarget. 2021; 12(18):1850-1858.
PMID: 34504657
PMC: 8416562.
DOI: 10.18632/oncotarget.27977.
Integrin β4 as a Potential Diagnostic and Therapeutic Tumor Marker.
Yang H, Xu Z, Peng Y, Wang J, Xiang Y
Biomolecules. 2021; 11(8).
PMID: 34439865
PMC: 8394641.
DOI: 10.3390/biom11081197.
Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer.
Huang R, Zheng Z, Xian S, Zhang J, Jia J, Song D
Bioengineered. 2021; 12(1):5289-5304.
PMID: 34402716
PMC: 8806927.
DOI: 10.1080/21655979.2021.1964252.
An Optimized Integrin α6-Targeted Magnetic Resonance Probe for Molecular Imaging of Hepatocellular Carcinoma in Mice.
Lin B, Zhang W, Zhao J, Zhou X, Li Y, Deng J
J Hepatocell Carcinoma. 2021; 8:645-656.
PMID: 34235103
PMC: 8244641.
DOI: 10.2147/JHC.S312921.
Rac1-mediated sustained β4 integrin level develops reattachment ability of breast cancer cells after anchorage loss.
Mori K, Higurashi M, Ishikawa F, Shibanuma M
Cancer Sci. 2021; 112(8):3205-3217.
PMID: 34036687
PMC: 8353950.
DOI: 10.1111/cas.14985.
EGFR-dependent tyrosine phosphorylation of integrin β4 is not required for downstream signaling events in cancer cell lines.
Te Molder L, Kreft M, Heemskerk N, Schuring J, de Pereda J, Wilhelmsen K
Sci Rep. 2021; 11(1):8675.
PMID: 33883672
PMC: 8060419.
DOI: 10.1038/s41598-021-88134-6.
BR-BCSC Signature: The Cancer Stem Cell Profile Enriched in Brain Metastases that Predicts a Worse Prognosis in Lymph Node-Positive Breast Cancer.
Dionisio M, Vieira A, Carvalho R, Conde I, Oliveira M, Gomes M
Cells. 2020; 9(11).
PMID: 33182375
PMC: 7695320.
DOI: 10.3390/cells9112442.
Interplay between Cell-Surface Receptors and Extracellular Matrix in Skin.
Kleiser S, Nystrom A
Biomolecules. 2020; 10(8).
PMID: 32796709
PMC: 7465455.
DOI: 10.3390/biom10081170.
Quantitative analysis of β1,6GlcNAc-branched N-glycans on β4 integrin in cutaneous squamous cell carcinoma.
Kariya Y, Oyama M, Ohtsuka M, Kikuchi N, Hashimoto Y, Yamamoto T
Fukushima J Med Sci. 2020; 66(3):119-123.
PMID: 32779579
PMC: 7790466.
DOI: 10.5387/fms.2020-12.
FAM83A exerts tumor‑suppressive roles in cervical cancer by regulating integrins.
Xu J, Lu W
Int J Oncol. 2020; 57(2):509-521.
PMID: 32626940
PMC: 7307588.
DOI: 10.3892/ijo.2020.5078.